WHAT IS ENVISION?
Envision is the most advanced in-office ophthalmic platform available, delivering precision nonsurgical eye care procedures. This intelligent programmable workstation provides customizable treatments to address common eye conditions such as dry eyes caused by Meibomian Gland Dysfunction (MGD).
KEY BENEFITS:
Envision deploys multiple complementary modalities which work synergistically:
- Forma-I: bipolar radiofrequency (RF)
- Lumecca-I: intense pulsed light (IPL)
- Morpheus8: subdermal adipose tissue remodeling (SARD)
- Forma: bipolar radiofrequency (RF)
Small-size applicators and precise depth control allow for procedures in the small, more delicate subdermal layers of the periorbital region.
Perform safe and effective, nonsurgical, office-based procedures to improve Meibomian Gland Dysfunction and reduce dry eye symptoms
TECHNOLOGIES ON THE WORKSTATION
FORMA-I
Forma-I is a treatment to address the symptoms of dry eye disease caused by Meibomian Gland Dysfunction (MGD). It is intended for use in the periorbital area and eyelids, and relieves inflammation of meibomian glands and eye irritation.
LUMECCA-I
Lumecca-I ensures precise, targeted, spot-size Intense Pulsed Light (IPL) procedures to treat inflammatory conditions in smaller zones. This technology was developed with an advanced Xenon flash lamp and is optimized for light and dark skin tones.
MORPHEUS8
Morpheus8 is a minimally invasive Subdermal Adipose Remodeling Device (SARD) designed to remodel collagen and coagulate adipose tissue. This interchangeable portfolio of microneedling tips, with different pin configurations (Prime 12 pin, Resurfacing 24 pin, Morpheus8 24 pin), provides clinicians with a modular solution to deliver customizable fractional treatments.
FORMA
Forma is a non-invasive, non-ablative, bipolar radiofrequency dermal heating technology. It is intended to deliver uniform heat for the treatment of mild to moderate facial wrinkles and rhytides. Built-in temperature controls allow the treatment to reach optimal end-points safely and effectively.
Approved intended use varies by country; please check with local providers or representatives. Individual treatment results may vary.
Clinical and peer-reviewed publications are published by a third party and based on physician experiences and study results. InMode does not take responsibility for or endorse the content provided by the independent practitioners as the language may differ than InMode manufacturer clearances.